Patent ID: 8470782

Claim:
A pharmaceutical formulation comprising: an effective dose of a tTGase inhibitor, wherein said tTGase inhibitory moiety is: wherein R 1 is quinolin-3-ylmethyl ester and R 2 is selected from the group consisting of 5-fluoro-1H-indol-3-yl, (S)-Bn, (S)—CO 2 Me, (S)-Me, (R)-Bn, (S)—CH 2 CONHBn, (S)-(1H-inol-yl)-methyl, (S)-(4-hydroxy-phenyl)-methyl, OMe, OtBu, Gly, Gly-NH 2 , LPY, LPF—NH 2 ; R 3 is selected from Cl, and Br; n is 0; and X is selected from the group consisting of O and NH.